Lassa fever virus peptides predicted by computational analysis induce epitope-specific cytotoxic-T-lymphocyte responses in HLA-A2.1 transgenic mice

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 10, 2005, Pages 1223-1230

  Boesen, Agnieszka ^a,c   Sundar, Krishnan ^a,d   Coico, Richard ^a,b  

^a CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; GAMMA INTERFERON; HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NUCLEOPROTEIN; VIRUS GLYCOPROTEIN;

ALGORITHM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HEMORRHAGIC FEVER; HOST RESISTANCE; IMMUNOHISTOCHEMISTRY; LASSA FEVER; LASSA VIRUS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRANSGENIC MOUSE; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; COMPUTER SIMULATION; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; HLA-A2 ANTIGEN; HUMANS; LASSA FEVER; LASSA VIRUS; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTES, CYTOTOXIC; VIRAL PROTEINS;

EID: 26944481921     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.10.1223-1230.2005     Document Type: Article

References (32)

1. Altman, J. D., P. A. Moss, P. J. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94-96.
2. Baize, S., J. Kaplon, C. Faure, D. Pannetier, M.-C. Georges-Courbot, and V. Deubel. 2004. Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J. Immunol. 172:2861-2869.
3. Bhasin, M., H. Singh, and G. P. S. Raghava. 2003. MHCBN: a comprehensive database of MHC binding and non-binding peptides. Bioinformatics 19:665-666.
4. Drosten, C., B. M. Kummerer, H. Schmitz, and S. Gunther. 2003. Molecular diagnostics of viral hemorrhagic fevers. Antivir. Res. 57:61-87.
5. Eberl, G., A. Sabbatini, C. Servis, P. Romero, J. L. Maryanski, and G. Corradin. 1993. MHC class I H-2kd-restricted antigenic peptides: additional constraints for the binding motif. Int. Immunol. 5:1489-1492.
6. Feltkamp, M. C., M. P. M. Vierboom, W. M. Kast, and C. J. Melief. 1994. Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity. Mol. Immunol. 31:1391-1401.
7. Fisher-Hoch, S. P., L. Hutwagner, B. Brown, and J. B. McCormick. 2000. Effective vaccine for Lassa fever. J. Virol. 74:6777-6783.
8. Foster, B., and C. Prussin. 2002. Detection of intracellular cytokines by flow cytometry, p. 6.21.1-6.24.15. In J. Coligan et al. (ed.), Current protocols in immunology. John Wiley & Sons Inc., Hoboken, N.J.
9. Hilleman, M. R. 2002. Overview: cause and prevention in biowarfare and bioterrorism. Vaccine 20:3055-3067.
10. Huang, Y. H., M. H. Tao, C. P. Hu, W. J. Syu, and J. C. Wu. 2004. Identification of novel HLA-A*0201-restricted CD8+ T-cell epitopes on hepatitis delta virus. J. Gen. Virol. 85:3089-3098.
11. Lenz, O., J. ter Meulen, H. Feldmann, H. D. Klenk, and W. Garten. 2000. Identification of a novel consensus sequence at the cleavage site of the Lassa virus glycoprotein. J. Virol. 74:11418-11421.
12. Lu, J., and E. Celis. 2000. Use of two predictive algorithms of the world wide web for the identification of tumor-reactive T-cell epitopes. Cancer Res. 60:5223-5227.
13. Lycke, N. Y., and R. F. Coico. 1996. ELISPOT assay for measurement of antigen-specific and polyclonal antibody responses, p. 7.14.1-7.14.7. In J. Coligan et al. (ed.), Current protocols in immunology. John Wiley & Sons Inc., Hoboken, N.J.
14. McCormick, J. B., I. J. King, P. A. Webb, C. L. Scribner, R. B. Craven, K. M. Johnson, L. H. Elliott, and R. Belmont-Williams. 1986. Lassa fever. Effective therapy with ribavirin. N. Engl. J. Med. 314:20-26.
15. McCormick, J. B., P. A. Webb, K. M. Krebs, K. M. Johnson, and E. S. Smith. 1987. A prospective study of the epidemiology and ecology of Lassa fever. J. Infect. Dis. 155:437-444.
16. McCormick, J. B., I. J. King, P. A. Webb, K. M. Johnson, R. O'Sullivan, E. S. Smith, S. Trippel, and T. C. Tong. 1987. A case-control study of the clinical diagnosis and course of Lassa fever. J. Infect. Dis. 155:445-455.
17. Micheletti, F., P. Monini, C. Fortini, P. Rimessi, M. Bazzaro, M. Andreoni, M. Giuliani, S. Traniello, B. Ensoli, R. Gavioli. 2002. Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8. Immunology 106:395-403.
18. Nijman, H. W., J. G. Houbiers, M. P. Vierboom, S. H. van der Burg, J. W. Drijfhout, J. D'Amaro, P. Kenemans, C. J. Melief, and W. M. Kast. 1993. Identification of peptide sequences that potentially trigger HLA-A2.1 restricted cytotoxic T lymphocytes. Eur. J. Immunol. 23:1215-1219.
19. Parker, K. C., M. A. Bednarek, and J. E. Coligan. 1994. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152:163-175.
20. Price, M. E., S. P. Fischer-Hoch, R. B. Craven, and J. B. McCormick. 1988. A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. Br. Med. J. 297:584-587.
21. Rammensee, H.-G., J. Bachman, N. P. Emmerich, O. A. Bachor, and S. Stevanovic. 1999. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50:213-219.
22. Ruppert, J., J. Sidney, E. Celis, R. T. Kubo, H. M. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929-937.
23. Schmitz, H., B. Kohler, T. Laue, C. Drosten, P. J. Veldkamp, S. Gunther, P. Emmerich, H. P. Geisen, K. Fleischer, M. F. Beersma, and A. Hoerauf. 2002. Monitoring of clinical and laboratory data in two cases of imported Lassa fever. Microbes Infect. 4:43-50.
24. Sette, A., A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W. M. Kast, C. J. M. Melief, C. Oseroff, L. Yuan, J. Ruppert, J. Sidney, M. D. Guercio, S. Southwood, R. T. Kubo, R. W. Chestnut, H. M. Grey, and F. V. Chisari. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:5586-5592.
25. Simmons, G., A. Lee, A. J. Rennekamp, X. Fan, P. Bates, and H. Shen. 2004. Identification of murine T-cell epitopes in Ebola virus nucleoprotein. Virology 318:224-230.
26. Singh, R. A., L. Wu, M. A. Barry. 2002. Generation of genome-wide CD8 T cell responses in HLA-A*0201 transgenic mice by an HIV-1 ubiquitin expression library immunization vaccine. J. Immunol. 168:379-391.
27. Sun, Y., M. Song, S. Stevanovic, C. Jankowiak, A. Paschen, H. G. Rammensee, and D. Schadendorf. 2000. Identification of a new HLA-A(*)0201-restricted T-cell epitope from the tyrosinase-related protein 2 (TRP2) melanoma antigen. Int. J. Cancer 87:399-404.
28. + T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein. J. Virol. 74:2186-2192.
29. ter Meulen, J., M. Badusche, J. Satoguina, T. Strecker, O. Lenz, C. Loeliger, M. Sakho, K. Koulemou, L. Koivogui, and A. Hoerauf. 2004. Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones. Virology 321:134-143.
30. Turcanova, V., and P. Hollsberg. 2004. Sustained CD8+ T-cell immune response to a novel immunodominant HLA-B*0702-associated epitope derived from an Epstein-Barr virus helicase-primase-associated protein. J. Med. Virol. 72:635-645.
31. Vonderheide, R. H., W. C. Hahn, J. L. Schultze, and L. M. Nadler. 1999. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity 10:673-679.
32. Zhou, X., U. M. Abdel Motal, L. Berg, and M. Jondal. 1992. In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides. Eur. J. Immunol. 22:3085-3090.